by Richard Daverman, PhD
November 7, 2013 -- China New Enterprise Investment, a growth capital firm, will invest $25.4 million to buy additional shares in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical. CNEI is said to have invested $20 million SFZJ earlier this year and owned 14% of the company’s Hong Kong-listed and domestic shares before the latest investment. SFZJ is an innovative drug company that listed on the Hong Kong Growth Enterprise Market in 2002. More details....
Stock Symbol: (HK: 8231)
Help employers find you! Check out all the jobs and post your resume.
